The immune system is a crucial player in tissue homeostasis and wound healing. A sophisticated cascade of events triggered upon injury ensures protection from infection and initiates and orchestrates healing. While the neonatal mammal can readily regenerate damaged tissues, adult regenerative capacity is limited to specific tissue types, and in organs such as the heart, adult wound healing results in fibrotic repair and loss of function. Growing evidence suggests that the immune system greatly influences the balance between regeneration and fibrotic repair. The neonate mammalian immune system has impaired pro-inflammatory function, is prone to T-helper type 2 responses and has an immature adaptive immune system skewed towards regulatory T cells. While these characteristics make infants susceptible to infection and prone to allergies, it may also provide an immunological environment permissive of regeneration.
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1) Fibrotic repair versus regeneration -is the immune system to blame?
Tissue injury induces a cascade of events to prevent further damage and start the healing process, which occurs by a variable combination of regeneration and fibrotic repair. While regeneration restores the original structures and functionality of the damaged tissue or organ, repair results in collagen deposition and scar formation, leading to functional impairments. The balance between regeneration and fibrotic repair depends on the degree of regenerative ability of the damaged tissue, which varies between tissues, species and developmental stages. While adult mammalian skin, skeletal muscle and liver can regenerate structure and function following damage to a certain degree, the adult heart has negligible capacity to regenerate.
Overall regenerative capacity of individual species seems to decline with increasing evolutionary complexity. It has been suggested previously that the progressive complexity of the adaptive immune system in vertebrates caused the evolutionary loss of regeneration [1] . However, existing examples of efficient regeneration in mammals [2] [3] [4] [5] [6] indicate that the genetic basis of successful regeneration has been retained and may be inducible if the required pathways are identified. It seems that the mammalian immune response has evolved to favour quick repair and therefore generally counteracts regeneration while the immune system of lower vertebrates still supports regenerative repair [7] [8] [9] . This phylogenetic trend is paralleled during ontogeny as regenerative ability in mammals declines rapidly during early postnatal development. Most research on mammalian regeneration has been performed in rodents, whose developing embryonic hearts undergo rapid growth and remodelling and adjust readily to environmental insults including nutrient deprivation, variations in litter size, changes in blood flow, as well as mechanical and volume loading [10] . Compared to adults, neonatal mammals have a striking capacity to regenerate their hearts in several experimental injury models including ligation of the left anterior descending artery, apical resection and cryoinjury [11] [12] [13] [14] [15] . In one study, neonatal mice mounted a regenerative response that restored lost myocardial tissue and function over a period of 3 weeks after surgical amputation of the ventricular apex. This was associated with a series of cellular events reminiscent of efficient cardiac regeneration in lower vertebrates, including formation of a blood clot,
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recruitment of inflammatory cells to the site of injury, epicardial cell activation, early extracellular matrix deposition and cardiomyocyte proliferation [13] .
There is however substantial controversy about the degree of regenerative capacity, as some groups do observe fibrotic repair in neonates [16] [17] [18] and it seems that outcome may be sensitive to variations in experimental details including type and extent of injury and the way and time point of assessing fibrosis. While there clearly is higher regenerative capacity in the neonatal compared to the adult heart, it may not always be efficient enough to achieve full regeneration. Even in settings of successful neonatal heart regeneration in mice, regenerative capacity is lost shortly after birth at postnatal day 7, which coincides with both the developmental window when rodent cardiomyocytes begin to lose their proliferative potential [19, 20] , but also with drastic alterations due to maturation of the immune system [21-23].
Differences in regenerative capacity between developmental stages is especially relevant for the question whether the immune system may affect the outcome of healing. The mammalian immune response is quantitatively and qualitatively different in the neonate and adult [24] [25] [26] . Importantly, immune responses further change upon ageing corresponding to a progressive decline in regenerative ability [27] .
Many factors have been suggested to contribute to and determine regenerative capacity, including environment (sterile prenatal or aquatic environment), the degree of tissue differentiation or the composition and degree of damage to the extracellular matrix. Here we speculate about the role of the immune system in tipping the balance between regeneration and fibrotic repair of the mammalian heart.
2) The immune response during healing of cardiac tissue damage
The most prevalent type of cardiac tissue injury is ischemia or ischemia/reperfusion following a myocardial infarct (MI). However, infections or autoimmune disease targeting the heart also cause cardiac tissue damage.
The regenerative capacity of the adult mammalian heart is minimal and healing is achieved by fibrotic repair replacing damaged tissue with a scar.
Quick establishment of a stable scar is important after acute damage to prevent fatal left ventricular rupture. However, due to its non-contractile
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character, scar tissue impairs heart function. To compensate for prolonged myocardial stress, healthy structures surrounding a wounded area are remodelled, which may result in dilation of the left ventricle and thinning of the ventricle wall, eventually leading to heart failure.
Early studies indicated that suppression of the inflammatory response following tissue injury may improve regeneration. However, experiments and clinical studies based on the idea that inflammation in general was detrimental to post-MI recovery used broad immunosuppression and had deleterious effects with enhanced adverse remodelling and increased mortality [28, 29] .
Even broadly targeting all phagocytic cells had adverse effects. Mice depleted of inflammatory cells died from cardiac rupture and atherothrombosis [30] and MI induced in atherosclerotic mice impaired healing [31] . Importantly, healing in human patients is also impaired under both strongly inflammatory (chronic ulcers: [32] , sepsis: [33] ) as well as under immunosuppressed (corticosteroids: [34] ) conditions. This demonstrates the importance of early inflammation and the need for a balanced and coordinated response for successful healing.
2.1) Early events initiating the immune response
The major cardiac resident immune cells are mast cells and macrophages, but small numbers of dendritic cells and lymphocytes have also been detected in the resting myocardium. Cells resident within the damaged tissue are naturally the first to be affected and respond to injury. As summarised in Figure 1 , necrotic cell death causes the release of intracellular molecules, which are sensed by the complement system and surrounding cells including tissue resident immune cells.
2.1.1) Danger Signals:
Danger associated molecular patterns (DAMPs): As any other tissue damage, cardiac tissue injury causes the release of DAMPs. These can be fragments of extracellular matrix or intracellular molecules, which are released passively upon necrotic cell death including prominent examples such as heat shock proteins (HSPs), high-mobility group box-1 (HMGB-1) and Interleukin-33.
DAMPs alert the immune system to damage by binding to pattern recognition
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receptors (PRR) expressed on both immune cells and structural cardiac cells such as cardiomyocytes, fibroblasts and endothelial cells. Fibroblasts are traditionally recognised for producing and remodelling extracellular matrix during repair, but they also respond to immunologic stimuli and have a crucial part in the orchestration of the healing process [35] . PRR activation on fibroblasts induces their proliferation, migration, myofibroblast differentiation, ECM turnover and production of fibrotic and inflammatory factors [36] .
Activated endothelial cells produce reactive oxygen species (ROS), inflammatory cytokines and adhesion molecules for circulating leukocytes.
Increased vascular permeability facilitates extravasation and migration of leukocytes into the myocardium. Importantly, neonate endothelial cells have been demonstrated to express lower levels of adhesion molecules such as PSelectin and will therefore impair leukocyte tissue infiltration [37, 38] . and TNF-α [39] [40] [41] . IL-10 and IL-23 are major contributors to regeneration in different settings. IL-10 is a potent anti-inflammatory cytokine, which plays an essential role in fetal regeneration. It regulates the inflammatory response, the extracellular matrix [42] , fibroblast function and differentiation [43] and endothelial progenitor cell function [44] . Experimental overexpression of IL-10 recapitulates the fetal regenerative phenotype in postnatal tissue [45, 46] . In a phase II clinical trial, recombinant IL-10 reduced scar formation in cutaneous wounds [47] . IL-23 deficiency leads to increased myocardial inflammation and decreased cardiac fibroblast activation, associated with impaired scar formation and adverse remodelling after MI [48] . IL-6 is a multifunctional cytokine and can have both regenerative and anti-inflammatory as well as pro-inflammatory activities [49] . In human infants, IL-6 has been shown to contribute to reduced neutrophil migration to inflammatory sites [50] which may be supportive of regeneration.
TNF-α and other pro-inflammatory cytokines on the other hand contribute to myocardial dysfunction by directly depressing contractility and inducing Substance P has been shown to mediate adverse myocardial remodelling by activating cardiac mast cells, leading to increased TNF-α and matrix metalloproteinase (MMP) activation with subsequent degradation of the extracellular matrix [67] . Moreover, mast cell inhibition with cromolyn sodium attenuates adverse left ventricular remodelling and dysfunction in experimentally induced myocarditis in rats [68] .
However, there is significant controversy over the effect of mast cells on outcome after myocardial tissue damage as many studies made use of mice lacking the receptor tyrosine kinase c-Kit (Mast/stem cell growth factor receptor (SCFR)) as a mast cell deficient model. It is now known that c-Kit is expressed not only by mast cells [69] but also by differentiated and dedifferentiating cardiomyocytes [70] [71] [72] . Moreover, Kit−/− mice have additional immunological defects in adult T and B cell development [73] , which may strongly impact on regenerative capacity (discussed below) and make interpretations drawn from studies using these mice very complicated. The both pro-inflammatory and angiogenic properties of mast cells as well as their localisation close to either infiltrating immune cells or new vessels during the course of myocardial healing, may suggest that comparable to macrophages they undergo functional changes depending on environment and are proinflammatory during the early inflammatory phase and regenerative during later healing stages.
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Information is limited on differences between circulating neonatal and adult mast cells and not available on tissue mast cells in neonates. However, neonatal mast cells and basophilic granulocytes isolated from the umbilical cord matrix and cord blood, respectively, secrete significantly more histamine after stimulation compared to these cells in the adult [74] . Neonatal mast cells therefore may be potent supporters of regeneration in neonatal mammals.
2.2.2) Tissue resident macrophages:
Macrophages are large immune effector cells specialised in recognising, engulfing and destroying target cells. DAMPs activate tissue resident macrophages to produce pro-inflammatory cytokines including TNF-α and IL-6, and chemokines such as C-X-C motif ligand (CXCL)1 and CXCL2, which stimulate recruitment of neutrophils [76] .
Macrophages are the predominant immune cell population in the resting myocardium, and are found throughout myocardial interstitial spaces interacting directly with capillary endothelial cells and cardiomyocytes [77] .
By inducing cardiomyocyte cell death at varying stages of post-natal development using a diphtheria toxin receptor (DTR)-based genetic system, it was demonstrated that a resident macrophage population expands in neonatal hearts after damage, produces minimal inflammation and is required for cardiac repair through the promotion of coronary angiogenesis and cardiomyocyte proliferation. Strikingly, injured neonatal hearts are not infiltrated by significant numbers of either circulating monocytes/macrophages or neutrophils [78] . During homeostasis, the adult heart still contains an embryonically-derived macrophage population (defined as CC chemokine receptor 2-(CCR2-) as compared to CCR2+ macrophages originating from circulating adult monocytes) with similar properties. They are more efficient at internalising debris and engulfing apoptotic cardiomyocytes, suggesting they
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have homeostatic roles reminiscent of the function of macrophages during embryonic development [79] . However, after injury, these cells are replaced or at least largely outnumbered by infiltrating pro-inflammatory monocytes and monocyte-derived macrophages, which have limited capacity to promote cardiac repair and generate inflammation and oxidative stress instead.
Inhibition of recruitment of circulating monocytes into the adult heart by blocking CCR2, resulted in expansion of the embryonically-derived resident macrophage population, decreased expression of inflammatory cytokines in the myocardium, blocked neutrophil infiltration and enhanced coronary angiogenesis [78] . Even without evident injury, progressive replacement of resident macrophages of embryonic origin with infiltrating monocyte-derived macrophages over time may contribute to worsening regenerative capacity [80] . Resident embryonically-derived macrophages are therefore likely to have critical roles in the tissue-repair response [31, 78] .
Importantly, the adult tissue resident macrophage population further changes its functional properties with ageing. The number of expressed immune response genes decreases, while expression of fibrogenic genes increases.
This is consistent with a potential role for cardiac macrophages in agingassociated cardiac fibrosis [81] .
Thus, an age-dependent progressive loss of regenerative embryonicallyderived tissue resident macrophages, and a parallel increase of the inflammatory capacity of circulating and infiltrating monocytes and monocytederived macrophages, strongly implicates changes of the immune system in changes in regenerative capacity.
2.3) Infiltrating immune cells
The numbers of lymphocytes are present in the myocardium under healthy conditions [50] , while both monocytes and neutrophils are only observed inside capillaries but not within myocardial tissue during steady state [79] . A summary of differences between adult and neonate infiltrating cell types is shown in Figure 2 . Growth Factor (VEGF) and MMP 9, by which they promote healing via myofibroblast accumulation, angiogenesis and deposition of collagen [31] .
2.3.1) Monocytes/Macrophages
However, macrophage production of MMP 9 and TGF-β are considered significant pro-fibrotic factors and inhibition of either can reduce fibrosis in models of myocardial infarction [83] and pressure overload [84] , respectively.
Initially this biphasic response was considered to be due to infiltration of the corresponding Ly-6C(hi) and Ly-6C(lo) monocyte subsets circulating the peripheral blood, which differentiated into macrophages once inside the cardiac tissue. Importantly, these two populations correspond to circulating CD14+CD16-and CD14+CD16+ monocytes in humans, which also infiltrate
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infarcted hearts early and late, respectively [85, 86] . However, recently it has been suggested that anti-inflammatory Ly-6C(lo) actually derive from Ly-6C(hi) cells, which display high plasticity and develop into either proinflammatory or anti-inflammatory macrophages depending on the respective environment [87] . Independent of their origin, the biphasic change in macrophage phenotype and function and an appropriate balance between the two subsets is now accepted to be crucial for efficient healing early after MI as well as a potential target to improve regeneration and inhibit adverse remodeling.
A recent study identified a number of qualitative and quantitative differences in the cellular immune response of efficiently regenerating 1-day-old and nonregenerative 14-day-old mice following myocardial infarction. Importantly, an increased abundance of macrophages and a difference in macrophage localisation was observed and depletion of macrophages using clodronate liposomes in neonatal mice blocked heart regeneration following MI [88] . As infiltration of circulating monocytes/macrophages is negligible in neonatal hearts, regeneration is largely mediated by the embryonically-derived resident macrophage population [78] which play a crucial role in regenerative processes and are required for neonatal heart regeneration.
2.3.2) Neutrophils:
Neutrophils are attracted by DAMPs and early cytokines/chemokines produced by macrophages in the damaged tissue.
They are the dominant cell type 24h after injury in terms of total numbers and play a central role in augmenting and shaping early inflammatory responses as they degrade necrotic tissue and recruit and activate macrophages to remove the debris. Neutrophils contain granules pre-loaded with effector molecules (azurocidin, cathelicidin, antimicrobial peptide LL-37 and cathepsin G) and produce additional IL-6, which recruits monocytes and activates endothelial cells [89, 90] . In addition, upon activation neutrophils undergo 'netosis', a form of cell death associated with release of decondensed chromatin including histones and proteases, a structure termed neutrophil extracellular traps (NETs). While NETs are effective in trapping and killing bacteria, they also are cytotoxic and thrombogenic [91] . Activated neutrophils then undergo apoptosis within a few hours and serve as additional attractant
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for infiltrating monocytes, while inhibiting additional influx of neutrophils [92] , which explains the brief window of neutrophil accumulation right after injury.
Several neutrophil-related measures in peripheral blood have been shown to correlate with prognosis and remodelling after acute myocardial infarct.
Peripheral neutrophil count and neutrophil/lymphocyte ratio predict adverse prognosis and remodelling after acute MI [93, 94] . Granule contents of neutrophils such as myeloperoxidase (MPO) [95] and proteinase 3 [96] can be used as markers for long-term mortality in MI patients.
These studies suggest that excessive neutrophil activation is detrimental after MI. However, targeting neutrophils in animal and clinical studies has resulted in contradicting outcomes. MMP 8 and 9, which are produced by neutrophils and degrade extracellular matrix, are elevated in patients with left ventricular rupture after MI [97] and inhibition of MMP 9 in mice attenuated left ventricular dilation and collagen accumulation [83] and promoted angiogenesis [98] .
Antibody-dependent inhibition of L-Selectin and P-Selectin to block neutrophil influx, lowered neutrophil accumulation and reduced necrosis after reperfusion [99] , while P-Selectin knockout mice did not show any differences in tissue damage despite a reduction in leukocyte accumulation [100] . Finally, animal experiments using antibody-dependent blocking of the CD11/CD18
integrin showed a very promising improvement of left ventricular function after ischemia/reperfusion damage [101] . However, the corresponding human antibody that was subsequently used in clinical studies, showed no effect [102] . Thus, although dampening the neutrophil response may be beneficial after MI, we still don't understand all the factors involved well enough to translate experimental findings into successful clinical trials.
Strikingly, in stark contrast to adults and in line with impaired neutrophil migration, negligible neutrophil numbers seem to infiltrate neonatal mouse hearts after DTR-induced cardiomyocyte death, which may strongly impact on intensity of inflammation and inflammatory tissue damage [78] . Significant functional differences between adult and neonate neutrophils may also account for enhanced neonatal regeneration. Human newborns have less neutrophils with significantly impaired function due to lower expression of activating TLR [103] and low levels of cell surface L-selectin and Mac-1 (CD11b/CD18) [104] leading to a 50% reduction in adhesion to endothelial
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cells and transmigration into tissue. The IL-6 dominated cytokine milieu in the first year of life further contributes to reduced neutrophil migration to inflammatory sites [50] .
In summary, there is convincing evidence that neutrophil induced inflammatory damage is detrimental after cardiac tissue damage. The impaired function of neonate neutrophils may be sufficient to support the initiation of the healing response but protect from excessive damage to allow quicker resolution of inflammation and more efficient regeneration. angiogenesis and improve cardiac function following infarction [107] . In line with this concept, a reduced NK cell activity in patients with coronary artery disease in comparison to healthy subjects has been described [108, 109] . NK cells are more abundant in peripheral blood of newborns than in adults [110] .
2.3.3) Natural Killer cells (NK)
Considering that NK cells are beneficial during regeneration, a higher number in neonates may provide additional support for the neonatal regenerative capacity. for non-self antigens [79, 111] . Additional infiltration of dendritic cells into infarcted areas of rat hearts after experimental MI has been demonstrated.
2.3.4) Dendritic cells

Depletion of bone marrow-derived DC exacerbated post-infarct left ventricular
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remodelling and was associated with enhanced inflammatory cytokine expression, MMP 9 activation and infiltration of pro-inflammatory Ly-6c(hi) monocytes/macrophages into the infarcted myocardium [112] .
These findings suggest that DC play a protective role against post-infarction left ventricular remodelling by regulating the homeostasis of monocytes and macrophages during the transition from inflammation to repair. The same group showed that decreased numbers of DC in human infarcted myocardial tissue were associated with increased macrophage infiltration, impaired reparative fibrosis, and the development of cardiac rupture after MI. Thus, DC modulate post-MI inflammation and the subsequent healing process [113] .
In human newborns, DC express lower MHC-II, CD80 and CD86 compared to adult cells indicating their inability to fully activate antigen-specific T-and B cell responses [114] [115] [116] . TLR stimulation of whole blood from human infants produces elevated levels of IL-10, IL-6 and IL-23 which creates a regenerative cytokine environment [50] . This lowered expression of co-stimulatory molecules and a bias against Th1-type cytokines such as IFN-γ may aid regenerative processes. 
2.3.5) Adaptive Lymphocytes
CD4+ T cells: CD4+ T cells are present in the myocardium under healthy
conditions and additional numbers of a primarily Th1 phenotype are recruited after myocardial infarct [50] . Activation of T cells after MI requires an intact TCR repertoire for self-antigen recognition and activated T cells are therefore auto-reactive [117] . Importantly, increased levels of α-MyHC antibodies can be detected in patients with dilated cardiomyopathy and after MI [118, 119] .
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and impairs survival after MI with increased neutrophil numbers and elevated numbers of inflammatory Ly-6C(hi) macrophages in the infarct zone [127] . An independent study confirms these results and shows in addition that Treg cells modulate the cardiac fibroblast phenotype, reducing expression of α-smooth muscle actin, decreasing expression of MMP 3 and attenuating contraction of fibroblast-populated collagen pads. This suggests that Treg cells exert anti-inflammatory and matrix-preserving properties after MI that may attenuate adverse post-infarction remodelling [124] . They therefore seem an excellent candidate for a central role in regulating fibrosis and regeneration and a very promising therapeutic target to improve cardiac repair.
Treg cells are present in higher frequency in human cord blood and neonatal lymph nodes compared to adult tissues [128, 129] . High fetal Treg cell numbers reflect a strong tendency of naive fetal T cells to differentiate into
Treg cells in response to maternal antigens that cross the placenta [130] . and TNF-α) [132] .
B lymphocytes: A small number of B cells is present in cardiac tissue under resting conditions [133] . B cell numbers in the myocardium increase after infarct. Their surface marker phenotype indicates that MI triggers the infiltration of circulating mature B cells [134] . Genetic or antibody-mediated depletion of B cells is beneficial after MI, leading to reduced levels of the chemokine (C-C motif) ligand 7 (CCL7) and lower pro-inflammatory Ly-6C(hi) monocyte infiltration, decreased infarct size, lessened left ventricular dilation and improved recovery of left ventricular function [133] . In contrast an earlier study showed that intra-myocardial injection of immature bone marrowderived B cells after acute myocardial infarction in rats improved the recovery of myocardial function [135] . While this may present a valuable therapeutic option, it is likely not relevant under physiological conditions as immature bone marrow-derived B cells won't reach the infarcted myocardium. Neonatal B cells are naive, lack antigenic exposure and have only a partially developed surface immunoglobulin repertoire [136] . This may reduce their ability to
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produce efficient antibodies and may be beneficial during regeneration, where auto-antibodies are detrimental.
3.) Summary and conclusion
From the studies cited in this review, it is clear that the immune system has a causative role to play in the decline of regenerative capacity with age. We have summarised available data on the adult and neonate immune system and the many intriguing differences that correlate with loss of regenerative where quick closing of skin wounds was a significantly more pressing problem than recovering from a heart attack. In modern society with antibiotics available to fight infection resulting in an aging population suffering from heart disease, this ancient survival mechanism has turned against us.
The comparably weak immune system of neonates on the other hand seems to support regeneration. Less inflammatory damage early on and a more balanced fibrotic response allow for a better outcome of healing (figure 3).
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These aspects of the immune system in human newborns and infants have received a great deal of attention as they impair defences against early infections, make infants significantly more prone to allergies and have important implications when designing vaccinations for children. However, the same insufficiencies may be the key to activating the immune cascade and healing response, while avoiding the excessive and ongoing inflammatory tissue damage caused in the adult.
It is increasingly appreciated that the immune system is more than a mere defence machinery against infections, but has an array of roles during reproduction, development and tissue homeostasis. In addition, looking at the immune system as one entity is a vast over-simplification, which has already brought several clinical trials using broad immunosuppression to a 
